Vivani Medical Stock (NASDAQ:VANI)


RevenueOwnershipFinancialsChart

Previous Close

$1.39

52W Range

$0.91 - $1.92

50D Avg

$1.47

200D Avg

$1.28

Market Cap

$79.76M

Avg Vol (3M)

$304.83K

Beta

3.32

Div Yield

-

VANI Company Profile


Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

37

IPO Date

Nov 19, 2014

Website

VANI Performance


VANI Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$-26.96M$-21.24M$-13.32M
Net Income$-25.65M$-6.54M$-12.13M
EBITDA$-26.61M$-19.16M$-12.98M
Basic EPS$-0.50$-0.17$-1.10
Diluted EPS$-0.50$-0.17$-1.10

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 19Mar 19, 20 | 4:30 PM
Q3 19Nov 15, 19 | 4:30 PM
Q2 19Aug 07, 19 | 4:30 PM

Peer Comparison


TickerCompany
IMAImageneBio Inc
MBOTMicrobot Medical Inc.
QIPTQuipt Home Medical Corp.
EDAPEdap Tms S.a.
CRDLCardiol Therapeutics Inc.
NSPRInspireMD, Inc.
ORMPOramed Pharmaceuticals Inc.
RCELAVITA Medical, Inc.
FONRFONAR Corporation
HYPRHyperfine, Inc.